v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 13,421 $ 12,217
Restricted cash - current 219
Accounts receivable, net of allowance of $541 and $582 at 2025 and 2024, respectively 5,847 3,824
Insurance receivable 4,316
Inventories, net 9,567 8,331
Prepaid expenses and other current assets 698 1,848
Total current assets 33,849 26,439
Property and equipment, net 3,019 3,573
Goodwill 3,764 3,764
Intangible assets, net 6,429 7,358
Operating lease right-of-use assets 4,912 5,483
Prepaid and other non-current assets 278 107
Total assets 52,251 46,724
Current liabilities:    
Accounts payable 4,768 5,668
Accrued liabilities 2,065 2,922
Accrued legal liabilities 4,316
Deferred revenue 5,675 6,804
Current contingent consideration 4,894 5,638
Current portion of operating lease liabilities 642 570
Total current liabilities 22,360 21,602
Long-term deferred revenue 555 2,064
Long term contingent consideration 4,724 6,126
Operating lease liabilities 4,794 5,436
Other liabilities 1,097 64
Total liabilities 33,530 35,292
Series A - Convertible preferred stock:    
Convertible preferred stock, Series A, par value $0.001; 10,000,000 shares authorized; 21,008 and 21,458 shares outstanding at 2025 and 2024, respectively 5,240 5,352
Stockholders’ equity:    
Common stock, par value $0.001; 300,000,000 shares authorized, 95,339,628 and 85,326,557 shares issued at 2025 and 2024, respectively 95 85
Additional paid in capital 596,960 567,926
Treasury stock, 4,015 shares at 2025 and 2024 (206) (206)
Accumulated deficit (583,368) (561,725)
Total stockholders’ equity 13,481 6,080
Total liabilities and stockholders’ equity $ 52,251 $ 46,724